Atea Pharmaceuticals, Inc. - Laporan Laba Rugi (TTM)

Atea Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US04683R1068

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Atea Pharmaceuticals, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
Revenue 49 115 175 208 351 285 225 192
Change (%) 135.68 52.69 18.75 69.07 -18.78 -21.16 -14.58
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 38 62 94 123 167 170 133 105
Change (%) 62.46 51.88 31.36 35.67 1.83 -21.68 -20.90
% of Revenue 78.18 53.89 53.61 59.30 47.59 59.66 59.27 54.89
Gross Operating Profit 11 53 81 85 184 115 92 87
Change (%) 398.07 53.63 4.18 117.74 -37.49 -20.40 -5.39
% of Revenue 21.82 46.11 46.39 40.70 52.41 40.34 40.73 45.11
SG&A 22 29 39 47 46 50 50 50
Change (%) 34.82 33.08 20.38 -2.04 8.26 1.09 -1.12
% of Revenue 44.50 25.45 22.19 22.49 13.03 17.37 22.27 25.78
R&D
Change (%)
% of Revenue
OpEx 60 91 133 170 213 220 183 155
Change (%) 52.44 45.85 28.14 25.31 3.21 -16.55 -15.50
% of Revenue 122.68 79.35 75.79 81.79 60.62 77.03 81.54 80.67
Operating Income -11 24 42 38 138 66 42 37
Change (%) -314.60 78.96 -10.67 265.66 -52.63 -36.64 -10.54
% of Revenue -22.68 20.65 24.21 18.21 39.38 22.97 18.46 19.33
Interest Expense
Change (%)
% of Revenue
Net Income -11 24 35 25 121 48 16 36
Change (%) -316.99 48.55 -29.96 390.37 -60.06 -67.92 129.64
% of Revenue -22.51 20.72 20.16 11.89 34.49 16.96 6.90 18.55

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista